NCI Bertagnolli: Drug shortages, potential NCI budget cuts strain the already-stressed system July 28, 2023Vol.49 No.30By Matthew Bin Han Ong
As U.S. courts, politicians take aim at preventive care, cervical cancer screening declines, HPV vaccine uptake stays uneven July 21, 2023Vol.49 No.29By Matthew Bin Han Ong
Conversation with The Cancer Letter St. Jude’s Heather Brandt: NCI cancer centers must leverage community trust to boost HPV vaccine uptake in children July 21, 2023Vol.49 No.29By Matthew Bin Han Ong
Conversation with The Cancer Letter NCI’s Douglas Lowy: HPV vaccination is important, but it’s even more important to get screened July 21, 2023Vol.49 No.29By Matthew Bin Han Ong
FreeGuest Editorial Playing Russian roulette with two bullets at Zaporizhzhia nuclear plant July 21, 2023Vol.49 No.29By Robert Peter Gale
FreeIn the Archives Cancer History Project book spotlight: “Simone’s Maxims” July 21, 2023Vol.49 No.29
FreeTrials & Tribulations Engineering-level molecular diagnosis: A necessity for cancer treatment—and for a successful Moonshot July 21, 2023Vol.49 No.29By Michael P. Castro
SCOTUS decision on denying service to LGBTQ+ people opens doors for discrimination in cancer care July 14, 2023Vol.49 No.28By Alexandria Carolan
Using ctDNA as an endpoint in your cancer clinical trial? FDA wants to hear from you July 14, 2023Vol.49 No.28By Matthew Bin Han Ong
